HyperglycemiaBlood GlucoseDiabetes Mellitus, ExperimentalInsulinGlucoseEpisode of CareDiabetes Mellitus, Type 2Hypoglycemic AgentsDelayed DiagnosisStreptozocinDiabetes MellitusPrenatal DiagnosisEarly DiagnosisRetrospective StudiesGlucose Tolerance TestTime FactorsSensitivity and SpecificityHypoglycemiaDiabetes Mellitus, Type 1Risk FactorsIslets of LangerhansTreatment OutcomeProspective StudiesDiagnosisHyperinsulinismAcute DiseaseInsulin ResistanceGlucagonHemoglobin A, GlycosylatedInsulin-Secreting CellsDiabetes ComplicationsFastingFollow-Up StudiesPostprandial PeriodPredictive Value of TestsInfant, NewbornPregnancyDiabetic AngiopathiesGlucose Clamp TechniqueRecurrenceTomography, X-Ray ComputedDiagnostic ErrorsGlycosuriaC-PeptideDiabetic KetoacidosisCohort StudiesIncidencePhlorhizinGlucokinaseGluconeogenesisPrognosisGlucose IntoleranceBiopsyLiverAge FactorsPrevalenceHyperglycemic Hyperosmolar Nonketotic ComaReproducibility of ResultsBiological MarkersDiabetic NephropathiesBody WeightMagnetic Resonance ImagingDisease Models, AnimalSeverity of Illness IndexRats, Sprague-DawleyReference ValuesDiagnosis, Computer-AssistedPancreasObesityNursing DiagnosisRats, WistarPregnancy in DiabeticsPolymerase Chain ReactionChoreaAlloxanRats, ZuckerOxidative StressCase-Control StudiesCritical IllnessMice, Inbred C57BLHyperglycinemia, NonketoticDisease ProgressionPreimplantation DiagnosisGlucagon-Like Peptide 1Diabetic NeuropathiesChronic DiseasePrediabetic StateSyndromeDiabetic RetinopathyInfusions, IntravenousFatal OutcomeUnited StatesRisk AssessmentGlycosylation End Products, AdvancedFetal DiseasesCross-Sectional StudiesHospitalizationAnalysis of VarianceDose-Response Relationship, DrugComorbidity